Who is Rekha Jhunjhunwala?

Rekha Jhunjhunwala is a Mumbai-based investor and the widow of stock market investor Rakesh Jhunjhunwala, who died in August 2022. She co-owns Rare Enterprises, the family investment firm whose name combines the first letters of Rakesh and Rekha, and controls the family's stakes in companies such as Titan, Metro Brands, Star Health and Inventurus Knowledge Solutions.

What is Rekha Jhunjhunwala's net worth in 2026?

The M3M Hurun India Rich List 2026 put the wealth of Rekha Rakesh Jhunjhunwala and family at Rs 75,800 crore, the highest among investors on the list. Forbes estimated her net worth at US$9.1 billion in its India Rich List of September 2026, ranking her No. 26 in India.

How did Rekha Jhunjhunwala become rich?

Most of the wealth was built by her husband Rakesh Jhunjhunwala, who began trading in 1985 with Rs 5,000 and made long-term bets on companies such as Titan, Crisil and Star Health. She held many of these investments jointly or in her own name, inherited the estate after his death in 2022, and has since overseen the portfolio with the team at Rare Enterprises.

Where is Rekha Jhunjhunwala from?

She was born on 12 September 1963 and grew up in Mumbai, in a large family; she was the second of six children. She married Rakesh Jhunjhunwala in 1987 and lives in Mumbai.

What was the Aptech insider trading case involving Rekha Jhunjhunwala?

SEBI alleged that Rakesh and Rekha Jhunjhunwala and several relatives traded Aptech shares in 2016 while in possession of unpublished price-sensitive information. In July 2021 they settled the case without admitting or denying the findings; Rekha's share of the settlement, disgorgement and interest was about Rs 3.2 crore, and the case is closed.

Who manages Rekha Jhunjhunwala's portfolio?

Rare Enterprises has continued to be run by Rakesh Jhunjhunwala's long-time lieutenants Utpal Sheth and Amit Goela, and Radhakishan Damani was reported in 2022 to be the main trustee of the estate. Rekha has said she relies on 'a good support system' and has not taken 'a deep dive into the market'.

Who will inherit the Jhunjhunwala fortune?

The estate passed mainly to Rekha Jhunjhunwala and the couple's three children. Several large holdings sit in discretionary trusts set up for the children and, since 2026, in a promoter entity called Sitara Partners LLP in which Rekha is a designated partner.

Rekha Jhunjhunwala: Life Story & Net Worth

Key facts
Born	12 September 1963, Mumbai
Family roots	A large Mumbai family; second of six children
Education	Reported to be a commerce graduate of the University of Mumbai
Family	Widow of investor Rakesh Jhunjhunwala (1960-2022); three children
Company/Group	Rare Enterprises (co-owner); a promoter of Inventurus Knowledge Solutions (IKS Health) and Star Health; family investor in Akasa Air
Wealth	Rs 75,800 crore with family, the top investor on the M3M Hurun India Rich List 2026; Forbes: US$9.1 billion, No. 26 in India (Sep 2026)
Known for	Taking over and steadily growing one of India’s best-known stock portfolios after her husband’s death

In October 2021, at a media conclave in New Delhi, a journalist told Rakesh Jhunjhunwala that his portfolio was now estimated at Rs 40,000 crore. India’s most famous investor waved the number away with a line borrowed from oil baron John Paul Getty: “If you can count it, you don’t have it.” Then he added something that sounded like a joke and turned out to be prophetic. “I just have one partner and one client: Rekha Jhunjhunwala.” His wife, he said, did not care whether she was a billionaire “or worth $200 million or $400 million” [11].

Ten months later he was gone. On 14 August 2022, a week after the first flight of the airline he had backed, Rakesh Jhunjhunwala died in Mumbai at 62 [16] [17]. The “only client” became the owner of one of the largest individual stock portfolios in the country.

She had never given a market interview. She had never run a company. “I don’t know how the transition from Mrs Jhunjhunwala to Rekha Jhunjhunwala happened,” she told Forbes India in 2024. “I never expected it. I was never prepared” [11].

Four years on, the M3M Hurun India Rich List 2026 puts the wealth of “Rekha Rakesh Jhunjhunwala & family” at Rs 75,800 crore, the highest of any investor in India, nearly six times the next name on that list [13] [14]. Forbes ranks her the 26th-richest Indian [8].

This is the story of a homemaker from a large Mumbai family who spent 35 years as the quiet half of a famous partnership, and then had to decide, very publicly, what to do with what it had built. It is also the story of that partnership, because her fortune cannot be understood without the man who made most of it, the decisions they took together, and the questions regulators asked along the way.

Where it began

Rekha Jhunjhunwala was born on 12 September 1963 in Mumbai [7] [9] [23]. She grew up in the city in a big, close family; a 2010 profile in Open magazine describes her as the second of six children [12]. Her husband later teased her about her suburban roots, calling her a girl from “andhera”, a pun on Andheri, while he was “a confirmed South Bombay boy” [12].

Little else about her early life is on the public record, and she has kept it that way. Profiles written after 2022 describe her as a commerce graduate of the University of Mumbai [23] [24]; she has not spoken about her schooling in any interview we could find. Rakesh, in a conversation with investor Ramesh Damani, described her as coming “from a wealthy family” that “always stood by me in my highs and lows” [11].

Her husband’s background is better documented. Rakesh Jhunjhunwala was born on 5 July 1960 into a Rajasthani family [16]; most accounts say he was born in Bombay, though some give Hyderabad [16] [59]. His father, Radheshyam Jhunjhunwala, was an income tax officer (some reports say he rose to commissioner) [12] [16]. Rakesh, the youngest of four children, studied at Sydenham College and qualified as a chartered accountant [12] [16].

He chose Dalal Street over an audit practice and started with Rs 5,000 in 1985, when the Sensex stood at around 150 [16] [18]. Years later he recalled that his father “wasn’t interested in my net worth but in how much I was going to give away” [17].

The marriage, 1987

Rekha and Rakesh married in 1987 [12] [59]. She was 23; he was 26 and still a small trader. In his telling, those early years were spartan. “She never asked for anything except an air-conditioned (AC) room,” he once said, recalling a time when “I didn’t have a car and an AC” [11].

The couple lived for years in the building his joint family had occupied since 1977, sharing three bedrooms with his parents [12]. “Our family is very close, we always live with our parents,” Rakesh said in 2010. “My mother is still the boss of the house, and Rekha allows that” [12].

The two were opposites in temperament. Open described her as “low-key and nurturing” and him as “loud, jocular even” [12]. What they shared was stubbornness: he applied it to markets, she applied it to family. They have three children [12].

The first break

The first break in this story belonged to Rakesh, and Rekha was there for it.

In 1986, a year before the wedding, he bought 5,000 shares of Tata Tea at Rs 43. Within three months they were at Rs 143 [16]. He sold for a profit of around Rs 5 lakh [18], and over 1986-89 he made Rs 20-25 lakh, serious money for a young trader at the time [16] [59].

In the early 1990s he made more on the other side of the trade. As Harshad Mehta drove stocks up with bank money, Rakesh was part of what Business Standard described as the “so-called ‘bear cartel’” that bet against those stocks; when the scam broke in 1992, the bears “had the last laugh” [19]. Short-selling was legal, and we found no case brought against him from that period. The gains gave him a base from which to become a long-term investor [19].

Rare Enterprises: “Ra” plus “Re”

At some point the couple set up a proprietary investment firm and named it after themselves: RaRe Enterprises, “Ra” for Rakesh and “Re” for Rekha [12] [16] [7]. Sources disagree on the year it was founded, with dates ranging from the early 1990s to 2003. What is clear is how it worked. RaRe had no outside clients. It invested the couple’s own money, and many of the biggest positions were held directly in Rekha’s name or jointly [23] [22].

“I have no motive, no customers, no clients, except Mrs Jhunjhunwala, and she’s a captive customer,” Rakesh told Open in 2010, laughing [12]. He repeated the line, in different forms, for the rest of his life [21].

The Titan bet

The trade that defined the family fortune began in 2002. Between March and June that year, Rakesh bought 664,250 shares of Titan, the Tata group’s watch and jewellery company, at around Rs 50 a share [12]. Adjusted for later splits and bonuses, Business Today put his average cost at about Rs 3 a share [25].

Titan was then known mainly as a watchmaker. The bet fitted the approach Rakesh described to Open: a long-term focus on businesses that feed India’s growing middle-class consumption [12]. He held through slumps and criticism, and he even wore Titan watches in public; Open noted that he owned a Patek Philippe but said it was “not as good as Titan” [12].

By 2010 the stake was worth over Rs 500 crore [12]. By 2026, the family’s roughly 5.3% stake in Titan was worth more than Rs 20,000 crore on its own [10] [32].

Building the empire

Rekha did not pick the stocks. She has said so plainly: “She knows nothing about stocks,” Rakesh once said, “but she has been my biggest support along with my dad and mother” [11]. Yet the empire was built in both their names, and understanding what she inherited means understanding how it was put together.

Two decades of concentrated bets, 2002-2022

Rakesh’s method, as he described it, was to back companies that would ride India’s middle-class consumption, in sectors such as construction, pharma and engineering, and to hold them for years [12]. “You can’t make money on borrowed knowledge,” he told Open. “People ask me for tips, I tell them it’s hazardous for health” [12].

Alongside Titan, early long-term positions included Crisil, the rating agency, and Lupin, the pharma company, both bought from around 2003 [22]. Over time the list grew to include Star Health, the health insurer, where Rakesh held 14.98% before its 2021 listing [35]; Metro Brands, the footwear retailer; Tata Motors; Indian Hotels; Federal Bank; Canara Bank; Fortis Healthcare; Nazara Technologies; and dozens of smaller holdings. At the end of June 2022 he had disclosed stakes in 47 listed companies [16].

He was also chairman of Aptech and Hungama Media, and sat on the boards of companies such as Concord Biotech, Geojit Financial Services and Viceroy Hotels [16]. He even produced three Hindi films: English Vinglish (2012), Shamitabh and Ki & Ka [25].

Forbes counted him among India’s richest people for years. In the Forbes India rich list current in early 2010 he ranked 58th, with US$915 million [12]; at his death in 2022 it estimated his net worth at US$5.8 billion [17] [16].

The last big bet: Akasa Air

In July 2021, at 61, Rakesh made the riskiest bet of his life. He invested about US$35 million for a stake of around 40% in a new low-cost airline being set up by former Jet Airways and GoAir executives, led by Vinay Dube and Aditya Ghosh [26] [25]. The company was named Akasa Air. Wikipedia, citing contemporary reports, says he later raised his stake to 46% [26].

Akasa operated its first commercial flight, Mumbai to Ahmedabad, on 7 August 2022 [26]. Rakesh was there. Seven days later he died [16].

August 2022: the handover

Rakesh Jhunjhunwala died early on 14 August 2022 at Breach Candy Hospital in Mumbai [16]. He left his assets, listed and unlisted, mainly to his wife and three children [25].

What happened next was, by most accounts, carefully planned. Business Today, citing a Moneycontrol report, said Radhakishan Damani, the founder of DMart, whom many in the market saw as Rakesh’s mentor, would be the main trustee of the estate, with long-time confidants Kalpraj Dharamshi and Amal Parikh as the other trustees. RaRe Enterprises would keep being run by Rakesh’s “two trusted lieutenants”, Utpal Sheth and Amit Goela [25]. (Damani’s own story is told in our profile of Radhakishan Damani.)

The lawyer Berjis Desai, a confidant of the family, later explained the logic. Rakesh, he said, had kept Rekha informed “at a 36,000 feet level”. “As a result, she can now shrewdly assess people and issues without going into granular details,” he said. “She instinctively knows whom to consult about what” [11].

The Hurun India Rich List 2022, published weeks later, already listed “Rekha Rakesh Jhunjhunwala & family”, with wealth of Rs 37,200 crore [6]. Forbes ranked her No. 30 in India that year, at US$5.9 billion [8].

The quiet custodian, 2022-2024

The early moves were small and deliberate. Through 2023, filings showed her trimming or exiting smaller and older positions. In July 2023 she sold about 6.25% of Rallis India in a single week, leaving a stake of about 2.28% [29]. By December 2023 she had exited Autoline Industries, Dishman Carbogen Amcis, Edelweiss Financial Services, Prozone Realty and Rallis, while preference shares in Raghav Productivity Enhancers and Sun Pharma Advanced Research converted into equity [11].

The core was left alone. “His portfolio has always done well, and earnings have compounded,” she said. “There is no need to mess up with a good thing” [11].

In August 2023, Concord Biotech, a Jhunjhunwala-backed fermentation-based drug maker, listed at Rs 900.05 against an issue price of Rs 741, a 21% premium [40]. By August 2025, family trusts held about 24.1% of the company [41].

She also did something her husband rarely did: she bought property as an investment. In November 2023, an LLP linked to her bought office space in Mumbai for about Rs 740 crore, including space in a building called The Capital in Bandra Kurla Complex for about Rs 601 crore and space in Chandivali for about Rs 138 crore [37]. Forbes India described it as part of a push into pre-leased commercial real estate, with three big transactions in six months [11].

The market did much of the rest. By Business Standard’s count, the stocks in her name were worth Rs 41,676 crore by March 2024, with Tata group companies making up about 61% of the value [30]. Forbes India, using a different data source and scope, put the portfolio at Rs 50,410 crore at the end of December 2023, up 49% in a year against a 20% rise in the Nifty [11].

The IKS listing, December 2024

The family’s second-largest listed asset today is one most investors had never heard of until 2024. Inventurus Knowledge Solutions (IKS Health), a Mumbai-based company that does outsourced clinical and administrative work for US healthcare providers, was co-founded by Sachin Gupta, and its promoters included Rekha Jhunjhunwala and three discretionary trusts set up for the couple’s children [38].

IKS went public in December 2024 through a pure offer for sale of about Rs 2,498 crore at a price band of Rs 1,265-1,329, listing on 19 December 2024; the money went to the selling shareholders, including the Jhunjhunwala family trusts, not the company [39] [38]. A year later Business Today described IKS as the Jhunjhunwalas’ “second-biggest stock bet” after Titan [31]. Forbes, too, lists Titan and IKS as her most valuable listed holdings [7].

2025-2026: rebalancing and a record

In June 2025 she sold about 29.75 lakh shares of Nazara Technologies, cutting her stake from about 7.1% to 3.7% [42]. In the September 2024 quarter she had already trimmed Canara Bank, selling about 45 lakh shares [43].

Meanwhile, the family stayed with Akasa. In 2025 the airline completed a fundraise of about US$125 million that brought in Premji Invest, 360 ONE and Claypond Capital; ch-aviation reported that the Jhunjhunwala family also contributed [27]. Akasa had grown to 31 destinations by January 2026 [26].

By Trendlyne’s count, cited by Business Today, the family’s listed holdings grew from Rs 33,517 crore at the end of 2022 to Rs 48,186 crore at the end of 2023, Rs 50,310 crore at the end of 2024 and Rs 62,994 crore by late December 2025, a 25% rise in 2025 alone [31]. Titan, her largest holding, rose 22% that year [31].

In 2026 the jeweller kept climbing. In April, after a strong quarterly update, Business Today valued her Titan stake at about Rs 21,000 crore [34]; by August, with the stock at a record high, at close to Rs 24,000 crore [33]. Business Standard reported that Titan and private banks helped her portfolio beat the market in the first quarter of FY27, with the stocks in her name rising from Rs 39,226 crore on 31 March 2026 to Rs 46,982 crore on 21 July 2026 [32].

How the wealth is held

The Jhunjhunwala fortune is not one company. It sits in several layers:

Shares in Rekha’s own name. For the September 2026 quarter, Trendlyne lists about two dozen disclosed holdings above 1%, worth roughly Rs 44,600 crore, led by Titan (about 5.3%, roughly Rs 20,900 crore), Metro Brands (14.4%), Fortis Healthcare, Federal Bank, the two Tata Motors companies, Crisil, Canara Bank, Karur Vysya Bank, Indian Hotels, NCC, Star Health and Jubilant Pharmova [10]. Filing dates and scope differ, which is why published figures for “her portfolio” vary.
Family trusts. Discretionary trusts for the three children hold large stakes in IKS and Concord Biotech, among others [38] [41].
Promoter vehicles. In June 2026, after the insurance regulator IRDAI approved the transmission of Rakesh’s 8.29 crore Star Health shares under the probate granted by the Bombay High Court on 18 December 2023, 7.82 crore of them were moved off-market to Sitara Partners LLP, in which Rekha is a designated partner. The LLP held 13.29% of Star Health; the company stressed this was “not an open-market sale” and not a promoter exit [35] [36].
Unlisted stakes and property. These include the family’s stake in Akasa Air, RaRe Enterprises itself, and the commercial real estate bought from 2023 [27] [37].

Rich lists add these layers up differently. Hurun put the family’s wealth at Rs 50,480 crore in 2025 (rank 47) [15] and Rs 75,800 crore in 2026 [13]. Forbes put her at US$8.7 billion in 2025 and US$9.1 billion in September 2026, No. 26 in India [8]. Its real-time estimate was US$8.6 billion on 20 October 2026 [7].

The setbacks and failures

The story of this family is often told as one long winning streak. It was not.

Market drawdowns. A concentrated portfolio swings hard. In the three months to June 2022, the family lost nearly Rs 3,500 crore on paper from Titan alone [45]. On 6 May 2024, after weak quarterly margins, Titan shares fell sharply and the value of her stake dropped by about Rs 800 crore within minutes [44]. In August 2025, Concord Biotech’s fall wiped about Rs 300 crore off the family trusts’ holding in two minutes [41]. In 2025, IKS fell 14% and Concord 37% even as the overall portfolio rose [31].

The duds. Not every bet paid. Business Standard’s obituary of Rakesh listed companies such as DHFL, A2Z Maintenance and DB Realty among his losing investments [19].

Akasa’s losses. Rakesh billed the airline as his biggest bet and risk [11], and it has been expensive. Akasa reported revenue of about Rs 4,636 crore and a net loss of about Rs 1,983 crore in FY25 [26]. It has also faced operational trouble: in 2023 it sued five pilots in the Bombay High Court for about Rs 21 crore each, alleging they left without serving their notice period [53], and in December 2024 the aviation regulator DGCA fined it Rs 10 lakh over training lapses [54]. In 2024, reports said the family was unlikely to join a large new equity round [28], though it did contribute to the 2025 raise [27].

The personal cost of the spotlight. For someone who had stayed out of public view for 35 years, the scrutiny after 2022 was itself a hard adjustment. “I am not used to so much attention,” she said [11].

Controversies and allegations

Rekha Jhunjhunwala has a short public record of controversy. One regulatory matter has named her personally, and it is closed. A few other matters concern her late husband or companies in which the family is a large shareholder.

SEBI’s Aptech insider-trading case, 2016-2021

Allegation: The Securities and Exchange Board of India (SEBI) examined trades in Aptech, the education company of which Rakesh was the non-executive chairman and a promoter. Aptech signed a non-disclosure agreement with a preschool business on 14 March 2016 and announced its entry into the preschool segment on 7 September 2016. SEBI treated the intervening period as one in which the news was unpublished price-sensitive information. It alleged that Rakesh and Aptech director Utpal Sheth had that information and passed it on, and that six people, including Rekha, Rakesh’s brother Rajeshkumar and other relatives, traded Aptech shares during that period. Rekha was charged under the rule against trading while in possession of such information; she was not charged with passing it on [1]. Mint reported in 2020 that Rajeshkumar and Rekha had bought 7,63,057 Aptech shares through block deals on 7 September 2016 [47]. SEBI issued a show-cause notice on 1 October 2020 [1].

Response: The family did not contest the charges in court. In February 2021 Rakesh filed a settlement (consent) application [48], and the applicants settled “without admitting or denying the findings of fact and conclusions of law” [1]. His lawyer later recalled Rakesh’s view of regulators: “Right or wrong, you should always defer to them to keep harmony” [49].

What happened next:

SEBI’s settlement order of 14 July 2021 recorded payments of settlement amounts, disgorgement and interest. Rakesh’s share came to about Rs 18.5 crore and Rekha’s to about Rs 3.2 crore; seven people covered by that order paid about Rs 28.5 crore in all [1] [46]. The widely reported figure of about Rs 37 crore also includes a separate settlement by other Aptech board members [46].
In April 2021, a SEBI adjudicating officer fined Aptech itself Rs 1 crore for not closing its trading window during the period [50].
In February 2023, SEBI barred two long-time associates of Rakesh in a related case. In May 2025 the Securities Appellate Tribunal set that order aside, holding that one one-minute phone call with Rakesh in 2016 could not establish that they were connected persons. The tribunal noted that Rakesh and his family had “opted for SEBI’s Settlement scheme” [3].

Status: Closed for Rekha Jhunjhunwala since July 2021, settled without admission of guilt. SEBI’s order reserves the right to reopen the case only if any representation by the applicants is found to be untrue [1].

SEBI disclosure case over Geometric, 2017-2018 (Rakesh Jhunjhunwala)

Allegation: A SEBI show-cause notice of March 2017 alleged that Rakesh Jhunjhunwala breached disclosure requirements of the 1992 insider-trading regulations in connection with shares of Geometric Ltd. The case concerned disclosures, not trading on inside information [2].

Response: He applied to settle.

Status: Closed. SEBI’s settlement order of 30 November 2018 recorded a payment of Rs 2,48,872, without admission of the findings [2].

Questions about trading ahead of news

Allegation: As India’s most-watched investor, Rakesh was often the subject of market talk that he traded ahead of big announcements. A PTI obituary noted that he “did feature in some cases of insider trading”, while describing him as carrying “lesser baggage” than market figures of the 1990s such as Harshad Mehta and Ketan Parekh [20].

Response: Rakesh consistently described himself as a long-term investor whose views were public, and close associates credited him with making markets more transparent. “Before him, the markets were known for unsavoury characters who ended up in jail. He changed that by being transparent,” his friend Kalpraj Dharamshi told Open [12].

Status: Apart from the Aptech and Geometric settlements described above, we found no regulatory finding or court case against Rakesh or Rekha Jhunjhunwala on these grounds.

Star Health data leak, 2024 (company matter)

Allegation: In September 2024, a hacker leaked data relating to about 31 million customers of Star Health, in which the Jhunjhunwala family is a promoter, and demanded a ransom of US$68,000. The hacker claimed the company’s chief information security officer had sold the data [51] [52].

Response: Star Health obtained a Madras High Court order to block access to the leaked data and said its investigation had not found any wrongdoing by the officer [51] [52]. No allegation in this matter was made against Rekha Jhunjhunwala.

Status: A company and cybersecurity matter; we found no regulatory or court finding against any family member.

There are no other court, regulatory or tax cases against Rekha Jhunjhunwala that we could find, as of 22 October 2026, and no reported disputes over the estate.

Giving back

Rakesh Jhunjhunwala was open about wanting to give money away. In July 2021 he said he generally gave about 25% of his annual income to charity and planned a foundation with Rs 400-500 crore of capital. “I have the money, but I do not have the will to spend it,” he said. “I don’t ask God for more wealth, but to give me the power to give it away” [55]. He appeared in the EdelGive Hurun Philanthropy List 2021 with donations of about Rs 50 crore [56]. His causes included education, through Agastya International Foundation, where he was a trustee, and Ashoka University; eye care; and organisations such as St Jude India ChildCare Centres and Friends of Tribals Society [22] [59].

Rekha has continued that work, mostly in eye care and education. “I am continuing with the Rare Family Foundation’s work,” she said in 2024 [11]. In March 2023 she joined the board of Sankara Eye Foundation India, and she sits on the boards of Sri Kanchi Kamakoti Medical Trust and Agastya International Foundation [57] [11]. “There is no future without education,” she said, recalling her husband’s love of books [11].

The most visible result came on 20 October 2024, when Prime Minister Narendra Modi inaugurated the R Jhunjhunwala Sankara Eye Hospital in Varanasi, built with the family’s support [58]. In his speech, Modi said “Rekha Ji is devoting considerable time to this noble work” [5]. In March 2023, Rakesh Jhunjhunwala was posthumously conferred the Padma Shri for trade and industry [4].

Succession

Succession in this family is less about a corner office and more about a structure.

Rakesh planned for the day he would not be there. Desai said he “structured his transition well by ensuring that people whom he trusted were able to steer the ship until the next-gen was ready” [11]. In practice that meant three layers: trusted trustees led by Damani; a professional team at RaRe under Utpal Sheth and Amit Goela; and family trusts for the three children [25] [38].

The legal side has taken years. The Bombay High Court granted probate of the estate on 18 December 2023, and only in 2026 did large blocks such as the Star Health shares finish moving through regulatory approvals into family entities like Sitara Partners LLP [35] [36].

Rekha herself has framed her role as custodian, not chief investor. “I just want to carry forward whatever he has done and whatever he built,” she said, adding that she would still rather be known as “Mrs Jhunjhunwala” [11]. We found no public executive role for the children in the family’s investments so far.

What their journey teaches

Know what you are good at, and hire for the rest. Rekha has not tried to become a second Big Bull. “You can’t replace him, you can’t imitate him and you can’t expect me to be him,” she said [11]. Keeping a trusted team in place and staying out of daily trading has, so far, protected and grown the portfolio.

Doing nothing is a decision, and often the best one. Most of the family’s gains since 2022 came from holding Titan and a few other core positions, not from trading. “There is no need to mess up with a good thing” is as good a summary of long-term investing as any [11].

Plan your succession before you need it. Trustees, managers, trusts and LLPs were all in place or quickly put in place. Families who leave this to chance often lose wealth in disputes; this one, at least in public, has had none.

Concentration builds fortunes and tests nerves. A single stock, Titan, still makes up close to half of the disclosed portfolio [10]. That is how it got so large, and also why it can lose Rs 800 crore in a morning [44]. (CapitalVia’s Insights section covers the basics of diversification and risk for ordinary investors.)

Settle with the regulator, but learn the lesson. The Aptech case shows how easily family members can be drawn into insider-trading rules when a relative sits on a company’s board. Clean compliance processes for everyone around a company insider are not optional.

Partnership counts even when one partner is invisible. For 35 years, Rekha was “the only client”. The name RaRe was not a romantic gesture alone; much of the wealth was already held in her name, which helped make the transition after 2022 smoother.

A profile for general reading, based on public records and reporting as of 22 October 2026. Not investment, tax or legal advice.